课题基金 / 基金详情

TREATMENT OF SEVERE SYSTEMIC LUPUS WITH MONTHLY INTRAVENOUS CYCLOPHOSPHAMIDE

TREATMENT OF SEVERE SYSTEMIC LUPUS WITH MONTHLY INTRAVENOUS CYCLOPHOSPHAMIDE
每月静脉注射环磷酰胺治疗严重系统性狼疮
批准号:
6113341
负责人:
WILLIAM J MC CUNE
金额:
$2.14万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

WILLIAM J MC CUNE的其他基金

相似基金

相关文献

中文摘要
翻译
患有严重系统性红斑狼疮的患者,主要是肾脏或神经系统疾病,将 每月接受环磷酰胺静脉滴注加治疗 每日口服强的松。在六个月结束时,将做出决定 关于令人满意地控制疾病活动的问题。患者 情况良好的患者将随机接受每日口服 硫唑嘌呤30个月或每3次静脉注射环磷酰胺 30个月。轻微照明弹的治疗效果将增加 强的松;主要照明弹将每月重新开始治疗 静脉注射环磷酰胺。服用硫唑嘌呤的病人 维持治疗将改为环磷酰胺维持治疗 心理治疗。该议定书的一个新特点将是使用 在所有合适的女性患者中植入孕激素(“Norpot”) 生育年龄。(在过去,我们通常使用诺普兰、 为此目的注射孕激素或口服避孕药)。
英文摘要
Patients with severe systemic lupus, primarily renal or neurologic, will be treated monthly with intravenous cyclophosphamide infusions plus daily oral prednisone. At the end of six months, a decision will be made regarding satisfactory control of disease activity. Patients who are doing well will be randomized to receive either daily oral azathioprine for 30 months or intravenous cyclophosphamide every 3 months for 30 months. Minor flares will be treated with increased prednisone; major flares will be treated by restarting monthly intravenous cyclophosphamide. Patients who flare on azathioprine maintenance therapy will be switched to cyclophosphamide maintenance therapy. A new feature of this protocol will be contraception using implanted progestins ("Norplant") in all suitable female patients of child-bearing age. (In the past we have generally used either Norplant, injectable progestins or oral contraceptives for this purpose).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RCT of GnRH-a for ovarian protection during CYC therapy for rheumatic disease
EFFICACY & SAFETY OF RITUXIMAB FOR MOD TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS
ENDOTHELIAL DYSFUNCTION IN CHILDREN & ADULTS W/ SYSTEMIC LUPUS ERYTHEMATOSUS
ENDOTHELIAL DYSFUNCTION IN CHILDREN & ADULTS W/ SYSTEMIC LUPUS ERYTHEMATOSUS
海外基金